Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Nanotechnology for Drug Delivery: Part I)
Volume: 21 Issue: 22
Author(s): Jian Zhong
Affiliation:
Export Options
About this article
Cite this article as:
Zhong Jian, Editorial (Thematic Issue: Nanotechnology for Drug Delivery: Part I), Current Pharmaceutical Design 2015; 21 (22) . https://dx.doi.org/10.2174/1381612821999150608102453
DOI https://dx.doi.org/10.2174/1381612821999150608102453 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Liprins in the Regulation of Tumor Cell Motility and Invasion
Current Cancer Drug Targets Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours
Current Drug Discovery Technologies Apoptosis-Inducing Activity of the S100A8/A9 Heterodimer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment
Current Molecular Medicine p53 as the Focus of Gene Therapy: Past, Present and Future
Current Drug Targets A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma
Current Cancer Drug Targets Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells
Current Medicinal Chemistry Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Current Pharmaceutical Design Active Targeting Strategies for Anticancer Drug Nanocarriers
Current Drug Delivery Spermine Metabolism and Anticancer Therapy
Current Cancer Drug Targets DNA Methylation Markers in Lung Cancer
Current Genomics Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Epigenetic Multiple Modulators
Current Topics in Medicinal Chemistry CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Mini-Reviews in Medicinal Chemistry CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy
Current Cancer Drug Targets ES-MDA: Enhanced Similarity-based MiRNA-Disease Association
Current Protein & Peptide Science Air Pollution and Lung Cancer
Current Respiratory Medicine Reviews